Fairvalue-Calculator Fairvalue-Calculator
EN DE

Intervacc AB (IVACC) Fair Value & Analysis

Healthcare · SE · Market cap 442M SEK

Pricekr 1.31
Fair Valuekr 0.4600
Upside-64.9%
Quality95/100
Evidence: Low Range kr 0.3000 – kr 0.5700

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Intervacc AB (IVACC) currently trades at kr 1.31, while our model-based Fair Value estimate is kr 0.4600 — implying the stock looks roughly 64.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Intervacc AB (publ) develops novel veterinary vaccines for animals in Sweden. The company's product pipeline includes Strangvac, a vaccine against equine strangles for horses; INV274, antigens for a vaccine against streptococcus suis for the treatment of weaned piglets; and INV412, a multi-component vaccine to protect against several bacteria which cause mastitis for treating cows. It also engages in marketing and distribution of veterinary products in the Nordic markets, which includes vaccines and pharmaceuticals for swine, horses, cattle, and sheep. The company was incorporated in 1983 and is based in Hägersten, Sweden.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -84% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is Intervacc AB (IVACC) undervalued?
As of Jun 25, 2026, our model estimates a fair value of kr 0.4600 versus a price of kr 1.31 — about −65% (overvalued). Model-based estimate, not financial advice.
What is the fair value of IVACC?
Our 21-model fair value for Intervacc AB is kr 0.4600 (as of Jun 25, 2026), built from audited fundamentals. The current price is kr 1.31.
What is the quality score of IVACC?
Intervacc AB has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.